Clinical Trials
3 trialsNCT02521649 2015-08-13
Dose-ranging Study to Evaluate Antibody Response to G17DT in Patients With Gastric Cancer
Cancer Advances Inc.
Phase 2 Completed
NCT02518529 2015-08-10
Study to Assess Tolerability and Safety and Antibody Response to G17DT in Gastric Cancer Patients
Cancer Advances Inc.
Phase 2 Completed
NCT02518373 2015-08-07
CC5
Cancer Advances Inc.
Phase 2 Completed